Select Quality Measure
Stroke is the third leading cause of death and the leading cause of serious, long-term disability in the United States. About 700,000 people experience a new or recurrent stroke each year. These quality measures have been shown to reduce complications and improve quality of life for patients diagnosed with stroke.
The rates displayed in these graphs are from data reported for discharges from January 1, 2016 through March 31, 2016.
Antithrombotic Therapy Day Two
- Data at this time suggest that antithrombotic therapy, such as aspirin, should be initiated within 48 hours of symptom onset in acute ischemic stroke to reduce stroke mortality as long as no contraindications exist.
Discharged on Statin Medication
- Clinical trials have convincingly demonstrated that intensive lipid lowering therapy was associated with a dramatic reduction in the rate of recurrent ischemic stroke. The reduction of LDL cholesterol below 100 mg/dl is now recommended for all patients with stroke or TIA.
- There are many examples of how patient education for specific chronic conditions have increased healthful behaviors, improved health status, and/or decreased health care costs of their participants. Patient education should include information about the event (e.g., cause, treatment, and risk factors), the role of various medications or strategies, as well as desirable lifestyle modifications to reduce risk or improve outcomes.
Assessed for Rehabilitation
- Effective rehabilitation interventions initiated early following a stroke can enhance recovery process and minimize function disability. Stroke rehabilitation should begin as soon as the diagnosis of stroke is established and life-threatening problems are under control.